Healthcare and Life Science
MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK
New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours Kadans has also completed on Barton House, a new research...
Time from EMA approval to CT outcome for first indication vs. AMSR
This post launches a series of infographics focused on pricing and market access trends of rare disease treatments in France. Each post in this series zooms into a specific PMA trend by leveraging RADAR, CRA’s orphan drug data repository that includes all orphan drugs granted EMA approv...
Impact of medicare price “negotiation” program on small and large molecule medicines
The Inflation Reduction Act (IRA) directs the U.S. federal government to set a “Maximum Fair Price” (MFP) for the medicines with the highest spending in Medicare. The MFP will be implemented for selected small molecule drugs as early as nine years after approval, and as early as 13 year...
VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy
Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease ...
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells ...
Living with paediatric asthma
A number of different management techniques can help in controlling asthma in children. The aim of these management techniques is to enable the child to have a “normal life”, free of asthma symptoms. This includes enabling the child to sleep without any asthmatic related disruptions, to...
Sable&Hawkes deliver campaign graphics and new product illustrations for global biotech
Sable&Hawkes have delivered product and marketing illustrations, icons and infographics for global biopharma and life sciences company Sartorius. ...
SolasCure selected for Innovate UK Global Incubator Programme in Houston
Programme delivered in partnership with the Texas Medical Centre Programme will support Aurase Wound Gel for future entry into US market, advancing SolasCure’s mission to transform chronic wound care for millions of patients worldwide Cambridge, UK 03 June 2024: SOLASCURE Ltd (Sol...
PhoreMost achieves second milestone in target discovery alliance with Boehringer Ingelheim
Milestone payment follows successful target identification and validation in separate project under same collaboration Cambridge, UK, 03 June 2024: PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. Th...
DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation
Cambridge and Newcastle UK: DefiniGEN Ltd., and Atelerix Ltd., announces they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US. The agreement between the companies combines DefiniGEN’s mechanistically relevant iPSC hepatocytes (Opti-Hep...